Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of LY2165766 on body weight in healthy subjects
NL-OMON33288Active, not recruiting
- Sponsor
- Chorus
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of LY2165766 in schizophrenia (3 arms), sponsored by Chorus. Primary endpoints: Tolerability of LY2165766 and Body weight gain compared with placebo. Started Aug 2009; status: active, not recruiting.
02
Drugs
LY2165766
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NL-OMON33288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33288.